Elucidating on

2017 Movember Foundation – PCF Challenge Award (

2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Joshua Lang, MD (University of Wisconsin), Howard Scher, MD (Memorial Sloan Kettering Cancer Center), Scott Dehm, Ph D (Masonic Cancer Center, University of Minnesota), Scott Tagawa, MD (Weill Cornell Medicine and New York-Presbyterian) Co-Investigators: Kimberly Ku, MD (University of Wisconsin) Project Title: Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate Description: What this means to patients: New treatments are critically needed for patients with advanced prostate cancer. Lang and team will conduct a clinical trial to test whether targeting TROP-2 with a drug-carrying antibody has promise for the treatment of prostate cancer patients and develop biomarkers that can be used to select patients who will benefit from this treatment.2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Chad Mirkin, Ph D (Northwestern University) Co-Investigators: Bin Zhang, MD, Ph D (Northwestern University), Timothy Kuzel, MD (Northwestern University), William Catalona, MD (Northwestern University), Andrew Lee, Ph D (Northwestern University) Project Title: Spherical Nucleic Acids as Therapeutic Vaccines for the Treatment of Prostate Cancer Description: What this means to patients: Therapies that effectively stimulate a person’s immune system to attack and kill tumor cells are highly promising but still underdeveloped in prostate cancer. Mirkin and team will develop and test a novel nanoparticle-based therapeutic prostate cancer vaccine in preclinical models, which may lead to a new immunotherapy for prostate cancer.Although it’s really fun to clone websites and and have everyone believe your version of reality, it’s also a little bit scary.

||

2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Joshua Lang, MD (University of Wisconsin), Howard Scher, MD (Memorial Sloan Kettering Cancer Center), Scott Dehm, Ph D (Masonic Cancer Center, University of Minnesota), Scott Tagawa, MD (Weill Cornell Medicine and New York-Presbyterian) Co-Investigators: Kimberly Ku, MD (University of Wisconsin) Project Title: Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate Description: What this means to patients: New treatments are critically needed for patients with advanced prostate cancer. Lang and team will conduct a clinical trial to test whether targeting TROP-2 with a drug-carrying antibody has promise for the treatment of prostate cancer patients and develop biomarkers that can be used to select patients who will benefit from this treatment.

Million) Principal Investigators: Joshua Lang, MD (University of Wisconsin), Howard Scher, MD (Memorial Sloan Kettering Cancer Center), Scott Dehm, Ph D (Masonic Cancer Center, University of Minnesota), Scott Tagawa, MD (Weill Cornell Medicine and New York-Presbyterian) Co-Investigators: Kimberly Ku, MD (University of Wisconsin) Project Title: Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate Description: What this means to patients: New treatments are critically needed for patients with advanced prostate cancer. Lang and team will conduct a clinical trial to test whether targeting TROP-2 with a drug-carrying antibody has promise for the treatment of prostate cancer patients and develop biomarkers that can be used to select patients who will benefit from this treatment.2017 Movember Foundation – PCF Challenge Award (

2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Joshua Lang, MD (University of Wisconsin), Howard Scher, MD (Memorial Sloan Kettering Cancer Center), Scott Dehm, Ph D (Masonic Cancer Center, University of Minnesota), Scott Tagawa, MD (Weill Cornell Medicine and New York-Presbyterian) Co-Investigators: Kimberly Ku, MD (University of Wisconsin) Project Title: Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate Description: What this means to patients: New treatments are critically needed for patients with advanced prostate cancer. Lang and team will conduct a clinical trial to test whether targeting TROP-2 with a drug-carrying antibody has promise for the treatment of prostate cancer patients and develop biomarkers that can be used to select patients who will benefit from this treatment.2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Chad Mirkin, Ph D (Northwestern University) Co-Investigators: Bin Zhang, MD, Ph D (Northwestern University), Timothy Kuzel, MD (Northwestern University), William Catalona, MD (Northwestern University), Andrew Lee, Ph D (Northwestern University) Project Title: Spherical Nucleic Acids as Therapeutic Vaccines for the Treatment of Prostate Cancer Description: What this means to patients: Therapies that effectively stimulate a person’s immune system to attack and kill tumor cells are highly promising but still underdeveloped in prostate cancer. Mirkin and team will develop and test a novel nanoparticle-based therapeutic prostate cancer vaccine in preclinical models, which may lead to a new immunotherapy for prostate cancer.Although it’s really fun to clone websites and and have everyone believe your version of reality, it’s also a little bit scary.

||

2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Joshua Lang, MD (University of Wisconsin), Howard Scher, MD (Memorial Sloan Kettering Cancer Center), Scott Dehm, Ph D (Masonic Cancer Center, University of Minnesota), Scott Tagawa, MD (Weill Cornell Medicine and New York-Presbyterian) Co-Investigators: Kimberly Ku, MD (University of Wisconsin) Project Title: Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate Description: What this means to patients: New treatments are critically needed for patients with advanced prostate cancer. Lang and team will conduct a clinical trial to test whether targeting TROP-2 with a drug-carrying antibody has promise for the treatment of prostate cancer patients and develop biomarkers that can be used to select patients who will benefit from this treatment.

Million) Principal Investigators: Chad Mirkin, Ph D (Northwestern University) Co-Investigators: Bin Zhang, MD, Ph D (Northwestern University), Timothy Kuzel, MD (Northwestern University), William Catalona, MD (Northwestern University), Andrew Lee, Ph D (Northwestern University) Project Title: Spherical Nucleic Acids as Therapeutic Vaccines for the Treatment of Prostate Cancer Description: What this means to patients: Therapies that effectively stimulate a person’s immune system to attack and kill tumor cells are highly promising but still underdeveloped in prostate cancer. Mirkin and team will develop and test a novel nanoparticle-based therapeutic prostate cancer vaccine in preclinical models, which may lead to a new immunotherapy for prostate cancer.Although it’s really fun to clone websites and and have everyone believe your version of reality, it’s also a little bit scary.

elucidating on-76elucidating on-58elucidating on-23

While there is more information available online than ever before, we are less willing to use it to form our opinions and instead increasingly rely on herd mentality propagated by our feeds. 97 percent of scientists agree that climate change is happening, and 95 percent of scientists believe that humans are the dominant cause.Yet the polls show that only 63% of Americans believe climate change is real.2017 Movember Foundation – PCF Challenge Award (

While there is more information available online than ever before, we are less willing to use it to form our opinions and instead increasingly rely on herd mentality propagated by our feeds. 97 percent of scientists agree that climate change is happening, and 95 percent of scientists believe that humans are the dominant cause.

Yet the polls show that only 63% of Americans believe climate change is real.

2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Ana Aparicio, MD (The University of Texas MD Anderson Cancer Center), Nicholas Navin, Ph D (The University of Texas MD Anderson Cancer Center), Theocharis Panaretakis, Ph D (The University of Texas MD Anderson Cancer Center), Peter Kuhn, Ph D (University of Southern California) Co-Investigators: Brian Chapin, MD (The University of Texas MD Anderson Cancer Center), James Hicks, Ph D (University of Southern California), Patricia Troncoso, MD (The University of Texas MD Anderson Cancer Center) Project Title: Impact of Local Therapy on Outcomes of Men with De Novo Metastatic Prostate Cancer within Molecularly Defined Subsets Description: What this means to patients: Some men who have metastatic prostate cancer at the time of diagnosis may benefit from treatment of the primary tumor in addition to standard systemic therapy. Aparicio and team will develop biomarkers that can be used to identify which of these patients will benefit from treatment of the primary prostate tumor.

These data will be used to guide planned phase III clinical trials and may lead to a new standard of care for these patients.

"; "Clear up the question of who is at fault"elaborate, expatiate, expound, lucubrate, dilate, flesh out, exposit, enlarge, expand - add details, as to an account or idea; clarify the meaning of and discourse in a learned way, usually in writing; "She elaborated on the main ideas in her dissertation" the sense of the provision, which, if it had been intended to comprehend senators, would naturally have referred the temporary power of filling vacancies to the recess of the State legislatures, who are to make the permanent appointments, and not to the recess of the national Senate, who are to have no concern in those appointments; and would have extended the duration in office of the temporary senators to the next session of the legislature of the State, in whose representation the vacancies had happened, instead of making it to expire at the end of the ensuing session of the national Senate.

||

While there is more information available online than ever before, we are less willing to use it to form our opinions and instead increasingly rely on herd mentality propagated by our feeds. 97 percent of scientists agree that climate change is happening, and 95 percent of scientists believe that humans are the dominant cause.Yet the polls show that only 63% of Americans believe climate change is real.2017 Movember Foundation – PCF Challenge Award ($1 Million) Principal Investigators: Ana Aparicio, MD (The University of Texas MD Anderson Cancer Center), Nicholas Navin, Ph D (The University of Texas MD Anderson Cancer Center), Theocharis Panaretakis, Ph D (The University of Texas MD Anderson Cancer Center), Peter Kuhn, Ph D (University of Southern California) Co-Investigators: Brian Chapin, MD (The University of Texas MD Anderson Cancer Center), James Hicks, Ph D (University of Southern California), Patricia Troncoso, MD (The University of Texas MD Anderson Cancer Center) Project Title: Impact of Local Therapy on Outcomes of Men with De Novo Metastatic Prostate Cancer within Molecularly Defined Subsets Description: What this means to patients: Some men who have metastatic prostate cancer at the time of diagnosis may benefit from treatment of the primary tumor in addition to standard systemic therapy. Aparicio and team will develop biomarkers that can be used to identify which of these patients will benefit from treatment of the primary prostate tumor.These data will be used to guide planned phase III clinical trials and may lead to a new standard of care for these patients."; "Clear up the question of who is at fault"elaborate, expatiate, expound, lucubrate, dilate, flesh out, exposit, enlarge, expand - add details, as to an account or idea; clarify the meaning of and discourse in a learned way, usually in writing; "She elaborated on the main ideas in her dissertation" the sense of the provision, which, if it had been intended to comprehend senators, would naturally have referred the temporary power of filling vacancies to the recess of the State legislatures, who are to make the permanent appointments, and not to the recess of the national Senate, who are to have no concern in those appointments; and would have extended the duration in office of the temporary senators to the next session of the legislature of the State, in whose representation the vacancies had happened, instead of making it to expire at the end of the ensuing session of the national Senate.

Million) Principal Investigators: Ana Aparicio, MD (The University of Texas MD Anderson Cancer Center), Nicholas Navin, Ph D (The University of Texas MD Anderson Cancer Center), Theocharis Panaretakis, Ph D (The University of Texas MD Anderson Cancer Center), Peter Kuhn, Ph D (University of Southern California) Co-Investigators: Brian Chapin, MD (The University of Texas MD Anderson Cancer Center), James Hicks, Ph D (University of Southern California), Patricia Troncoso, MD (The University of Texas MD Anderson Cancer Center) Project Title: Impact of Local Therapy on Outcomes of Men with De Novo Metastatic Prostate Cancer within Molecularly Defined Subsets Description: What this means to patients: Some men who have metastatic prostate cancer at the time of diagnosis may benefit from treatment of the primary tumor in addition to standard systemic therapy. Aparicio and team will develop biomarkers that can be used to identify which of these patients will benefit from treatment of the primary prostate tumor.These data will be used to guide planned phase III clinical trials and may lead to a new standard of care for these patients."; "Clear up the question of who is at fault"elaborate, expatiate, expound, lucubrate, dilate, flesh out, exposit, enlarge, expand - add details, as to an account or idea; clarify the meaning of and discourse in a learned way, usually in writing; "She elaborated on the main ideas in her dissertation" the sense of the provision, which, if it had been intended to comprehend senators, would naturally have referred the temporary power of filling vacancies to the recess of the State legislatures, who are to make the permanent appointments, and not to the recess of the national Senate, who are to have no concern in those appointments; and would have extended the duration in office of the temporary senators to the next session of the legislature of the State, in whose representation the vacancies had happened, instead of making it to expire at the end of the ensuing session of the national Senate.

If now we were to try to penetrate to the soul of Quasimodo through that thick, hard rind; if we could sound the depths of that badly constructed organism; if it were granted to us to look with a torch behind those non-transparent organs to explore the shadowy interior of that opaque creature, to his obscure corners, his absurd no-thoroughfares, and suddenly to cast a vivid light upon the soul enchained at the extremity of that cave, we should, no doubt, find the unhappy Psyche in some poor, cramped, and ricketty attitude, like those prisoners beneath the Leads of Venice, who grew old bent double in a stone box which was both too low and too short for them.

Description: What this means to patients: New treatment strategies are needed for patients with hormone therapy-resistant prostate cancer.

crystalise, crystalize, crystallise, shed light on, sort out, crystallize, elucidate, illuminate, enlighten, straighten out, clear up, clear - make free from confusion or ambiguity; make clear; "Could you clarify these remarks?

Apparently their initial concern about not being hyper-linked properly escalated to a discussion about the necessity to acquire the new competitor — Clone Zone the startup.

Of course we were psyched about the fact that Clone Zone worked so well, spreading like wildfire form share to share.

So if you want to have your picture in the New York times you can chose an existing NYTimes article, add your picture, edit the headline and text and voila! at least within your group of friends that fall for the clone.